FDA Issues Guidance on Compounding Starter Parenteral Nutrition Drug Products for Neonates

The U.S. Food and Drug Administration (FDA) has announced the publication of guidance on 'Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates.' This guidance addresses critical aspects of patient safety and clinical practice for a vulnerable population, aiming to ensure the safe and effective preparation of these essential medications.